Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Growth Retardation and Adult Height in Children with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Haruko Shima, Chikako Tono, Akihiko Tanizawa, Masaki Ito, Akihiro Watanabe, Yuki Yuza, Kazuko Hamamoto, Hideki Muramatsu, Masahiko Okada, Shoji Saito, Hiroaki Goto, Masaru Imamura, Akiko M Saito, Souichi Adachi, Eiichi Ishii, Hiroyuki Shimada

Blood (2024) 144 (Supplement 1): 4537.

https://doi.org/10.1182/blood-2024-198938

Published: 2024

Journal Articles

PRC2-Mediated Apoptosis Evasion Is a Therapeutic Target of MDS/AML Harboring Inv(3)/t(3;3) and -7

Hiroyoshi Kunimoto, Ayaka Miura, Maiko Sagisaka, Mieko Ito, Daisuke Honma, Shinji Tsutsumi, Takayuki Sakuma, Takuma Ohashi, Hiroshi Teranaka, Junji Ikeda, Takashi Toya, Yuka Harada, Noriko Doki, Sheng F. Cai, Akihide Yoshimi, Hiroaki Goto, Ross L Levine, Hideaki Nakajima

Blood (2023) 142 (Supplement 1): 2803.

https://doi.org/10.1182/blood-2023-178436

Published: 2023

Journal Articles

The orally bioavailable GSPT1/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemia

Yunchao Chang, Fatemeh Keramatnia, Pankaj S. Ghate, Gisele Nishiguchi, Qingsong Gao, Ilaria Iacobucci, Lei Yang, Divyabharathi Chepyala, Ashutosh Mishra, Anthony A. High, Hiroaki Goto, Koshi Akahane, Junmin Peng, Jun J. Yang, Marcus Fischer, Zoran Rankovic, Charles G. Mullighan

Blood (2023) 142 (7): 629–642.

https://doi.org/10.1182/blood.2022017813

Published: 2023

Includes: Supplemental data

Journal Articles

Degradation of Janus kinases in CRLF2 -rearranged acute lymphoblastic leukemia

Blood (2021) 138 (23): 2313–2326.

https://doi.org/10.1182/blood.2020006846

Published: 2021

Includes: Supplemental data

Journal Articles

Clonal Evolution Pattern and Prognostic Significance of Clonal Architecture in KMT2A -Rearranged Acute Myeloid Leukemia

Blood (2021) 138 (Supplement 1): 2358.

https://doi.org/10.1182/blood-2021-146699

Published: 2021

Journal Articles

Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL

Yaqi Zhao, Ibrahim Aldoss, Chunxu Qu, Jeremy Chase Crawford, Zhaohui Gu, Emma K. Allen, Anthony E. Zamora, Thomas B. Alexander, Jeremy Wang, Hiroaki Goto, Toshihiko Imamura, Koshi Akahane, Guido Marcucci, Anthony S. Stein, Ravi Bhatia, Paul G. Thomas, Stephen J. Forman, Charles G. Mullighan, Kathryn G. Roberts

Blood (2021) 137 (4): 471–484.

https://doi.org/10.1182/blood.2020006287

Published: 2021

Includes: Supplemental data

Journal Articles

Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL

Blood (2020) 136 (20): 2319–2333.

https://doi.org/10.1182/blood.2019004090

Published: 2020

Includes: Supplemental data

Journal Articles

Etoposide, Cytarabine and Mitoxantrone- or Fludarabine, Cytarabine and Granulocyte Colony-Stimulating Factor-Based Intensive Reinduction Chemotherapy Is Recommended for Children with Relapsed Acute Myeloid Leukemia: The Results from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R Study

Hiroshi Moritake, MD PhD, Shiro Tanaka, PhD, Takako Miyamura, MD PhD, Hideki Nakayama, MD, Norio Shiba, MD PhD, Akira Shimada, MDPhD, Kiminori Terui, MD PhD, Yuki Yuza, MD PhD, Katsuyoshi Koh, MD, Hiroaki Goto, MD, PhD, Harumi Kakuda, MD PhD, Akiko M Saito, MD PhD, Daisuke Hasegawa, MD PhD, Shotaro Iwamoto, MD, Takashi Taga, MD PhD, Souichi Adachi, MD PhD, Daisuke Tomizawa, MD PhD

Blood (2020) 136 (Supplement 1): 6.

https://doi.org/10.1182/blood-2020-133272

Published: 2020

Journal Articles

Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia

Blood (2019) 134 (23): 2036–2045.

https://doi.org/10.1182/blood.2019000069

Published: 2019

Includes: Supplemental data

Journal Articles

Hematopoietic Stem-Cell Transplantation in Children with Refractory Acute Myeloid Leukemia

Yasuhiro Okamoto, MD, Kazuko Kudo, MD PhD, Ken Tabuchi, MD, Daisuke Tomizawa, MD PhD, Takashi Taga, MD PhD, Hiroaki Goto, MD, Hiromasa Yabe, MD, PhD, Yozo Nakazawa, MD, PhD, Katsuyoshi Koh, MD, Kazuhiro Ikegame, MD PhD, Nao Yoshida, MD PhD, Naoyuki Uchida, MD PhD, Kenichiro Watanabe, MD PhD, Yuuki Koga, MD PhD, Masami Inoue, MD, Koji Kato, MD PhD, Yoshiko Atsuta, MD PhD, Hiroyuki Ishida, MD, PhD

Blood (2018) 132 (Supplement 1): 4632.

https://doi.org/10.1182/blood-2018-99-111322

Published: 2018

Journal Articles

Hematopoietic Stem Cell Transplantation in Children with Refractory Acute Lymphoblastic Leukemia

Yasuhiro Okamoto, MD, Yozo Nakazawa, MD, PhD, Masami Inoue, MD, Kenichiro Watanabe, MD PhD, Hiroaki Goto, MD, Nao Yoshida, MD PhD, Maiko Noguchi, MD, Atsushi Kikuta, MD, Koji Kato, MD PhD, Yoshiko Hashii, MD PhD, Yoshiko Atsuta, MD PhD, Motohiro Kato, MD PhD

Blood (2018) 132 (Supplement 1): 2173.

https://doi.org/10.1182/blood-2018-99-111301

Published: 2018

Journal Articles

The Outcome of Relapsed Childhood Core Binding Factor Acute Myeloid Leukemia: A Report from the JPLSG AML-05R Study

Hiroshi Moritake, MD PhD, Shiro Tanaka, PhD, Hideki Nakayama, MD PhD, Takako Miyamura, MD PhD, Shotaro Iwamoto, MD PhD, Akira Shimada, MD PhD, Kiminori Terui, MDPhD, Akiko M. Saito, Norio Shiba, MD PhD, Yasuhide Hayashi, MD PhD, Daisuke Tomizawa, MD PhD, Takashi Taga, MD PhD, Hiroaki Goto, MD PhD, Atsushi Manabe, MD PhD, Keizo Horibe, MD PhD, Shuki Mizutani, MD PhD, Souichi Adachi, MD PhD

Blood (2015) 126 (23): 2516.

https://doi.org/10.1182/blood.V126.23.2516.2516

Published: 2015

Journal Articles

Genetic Susceptibility Loci for Childhood Acute Lymphoblastic Leukemia Among Japanese

Blood (2015) 126 (23): 3731.

https://doi.org/10.1182/blood.V126.23.3731.3731

Published: 2015

Journal Articles

Analysis of Copy Number Abnormalities of 86 Acute Lymphoblastic Leukemia Cell Lines Based on the Genetic Subtypes

Chihiro Tomoyasu, MD, Toshihiko Imamura, MD, Mio Yano, MD, Daisuke Asai, MD, Meixian Huang, MD, Hiroaki Goto, MD PhD, Akira Shimada, MD PhD, Takeshi Inukai, MD PhD, Kanji Sugita, MD PhD, Hajime Hosoi, MD

Blood (2015) 126 (23): 1424.

https://doi.org/10.1182/blood.V126.23.1424.1424

Published: 2015

Journal Articles

Phase I/II Clinical Trial of Erwinia Asparaginase (Erwinase R ) in Combination with Prednisolone, Vincristine and Pirarubicin in Children and Young Adults with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

Chitose Ogawa, MD, Atsushi Manabe, MD PhD, Hiroaki Goto, MD PhD, Katsuyoshi Koh, MD, Daisuke Tomizawa, MD PhD, Keitaro Fukushima, MD PhD, Ken-ichiro Watanabe, MD PhD, Keizo Horibe, MD, Atsushi Kikuta, MD PhD, Mitsuma Hamada, PhD, Akira Ohara, MD PhD

Blood (2014) 124 (21): 3657.

https://doi.org/10.1182/blood.V124.21.3657.3657

Published: 2014

Journal Articles

Risk-Oriented Therapy for Myeloid Leukemia of Down Syndrome: A Nationwide Prospective Study By the Japanese Pediatric Leukemia / Lymphoma Study Group (JPLSG)

Blood (2014) 124 (21): 3668.

https://doi.org/10.1182/blood.V124.21.3668.3668

Published: 2014

Journal Articles

Comparison Of Intravenous With Oral Busulfan In Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative Conditioning Regimens For Pediatric Acute Leukemia

Motohiro Kato, Yoshiyuki Takahashi, MD, PhD, Daisuke Tomizawa, MD, PhD, Yasuhiro Okamoto, MD, Jiro Inagaki, MD, PhD, Katsuyoshi Koh, MD, Atsushi Ogawa, MD, Keiko Okada, Yuko Cho, MD, PhD, Junko Takita, MD, Hiroaki Goto, MD., PhD, Hisashi Sakamaki, MD, PhD, Hiromasa Yabe, Keisei Kawa, MD, Ritsuro Suzuki, MD, Kazuko Kudo, MD, PhD, Koji Kato, MD, PhD

Blood (2013) 122 (21): 3397.

https://doi.org/10.1182/blood.V122.21.3397.3397

Published: 2013

Journal Articles

Poor Prognosis With Different Induction Rate Was Observed In Children With Acute Myeloid Leukemia and FLT3 -ITD According To The ITD/WT Allelic Ratio: A Result From The Japanese Pediatric Leukemia/Lymphoma Study Group

Blood (2013) 122 (21): 3891.

https://doi.org/10.1182/blood.V122.21.3891.3891

Published: 2013

Journal Articles

Correlation of Clinical Features with the Mutational Status of GM-CSF Signaling Pathway-Related Genes in Children with Juvenile Myelomonocytic Leukemia

Nao Yoshida, MD, Hiroshi Yagasaki, MD, PhD, Ayami Yoshimi, MD, PhD, Yoshiyuki Takahashi, MD, PhD, Yinyan Xu, Makito Tanaka, MD, Nobuhiro Watanabe, MD, PhD, Kimikazu Matsumoto, MD, PhD, Koji Kato, MD, PhD, Junichi Ueyama, MD, PhD, Hiroko Inada, MD, PhD, Hiroaki Goto, MD, PhD, Miharu Yabe, MD, PhD, Junichi Mimaya, MD, PhD, Akira Kikuchi, MD, PhD, Atsushi Manabe, MD, PhD, Seiji Kojima, MD, PhD

Blood (2007) 110 (11): 1528.

https://doi.org/10.1182/blood.V110.11.1528.1528

Published: 2007

Journal Articles

Induction of Death Receptors for TRAIL, a Cytotoxic Factor for GVL Effect, by Oncogenic Fusion E2A-HLF Derived from t(17;19)-Positive Acute Lymphoblastic Leukemia.

Xiaochun Zhang, Takeshi Inukai, Koshi Akahane, Kinuko Hirose, Itaru Kuroda, Hiroko Honna, Kumiko Goi, Keiko Kagami, Toshiya Inaba, Hidemitsu Kurosawa, Hiroaki Goto, Mikiya Endo, Hideo Yagita, A. Thomas Look, Kanji Sugita

Blood (2007) 110 (11): 2785.

https://doi.org/10.1182/blood.V110.11.2785.2785

Published: 2007

NARROW

Growth Retardation and Adult Height in Children with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

PRC2-Mediated Apoptosis Evasion Is a Therapeutic Target of MDS/AML Harboring Inv(3)/t(3;3) and -7

The orally bioavailable GSPT1/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemia

Degradation of Janus kinases in CRLF2 -rearranged acute lymphoblastic leukemia

Clonal Evolution Pattern and Prognostic Significance of Clonal Architecture in KMT2A -Rearranged Acute Myeloid Leukemia

Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL

Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL

Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia

Hematopoietic Stem-Cell Transplantation in Children with Refractory Acute Myeloid Leukemia

Hematopoietic Stem Cell Transplantation in Children with Refractory Acute Lymphoblastic Leukemia

The Outcome of Relapsed Childhood Core Binding Factor Acute Myeloid Leukemia: A Report from the JPLSG AML-05R Study

Genetic Susceptibility Loci for Childhood Acute Lymphoblastic Leukemia Among Japanese

Analysis of Copy Number Abnormalities of 86 Acute Lymphoblastic Leukemia Cell Lines Based on the Genetic Subtypes

Phase I/II Clinical Trial of Erwinia Asparaginase (Erwinase R ) in Combination with Prednisolone, Vincristine and Pirarubicin in Children and Young Adults with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

Risk-Oriented Therapy for Myeloid Leukemia of Down Syndrome: A Nationwide Prospective Study By the Japanese Pediatric Leukemia / Lymphoma Study Group (JPLSG)

Comparison Of Intravenous With Oral Busulfan In Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative Conditioning Regimens For Pediatric Acute Leukemia

Poor Prognosis With Different Induction Rate Was Observed In Children With Acute Myeloid Leukemia and FLT3 -ITD According To The ITD/WT Allelic Ratio: A Result From The Japanese Pediatric Leukemia/Lymphoma Study Group

Correlation of Clinical Features with the Mutational Status of GM-CSF Signaling Pathway-Related Genes in Children with Juvenile Myelomonocytic Leukemia

Induction of Death Receptors for TRAIL, a Cytotoxic Factor for GVL Effect, by Oncogenic Fusion E2A-HLF Derived from t(17;19)-Positive Acute Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only